Breadcrumb
- Home /
- Research /
- Researcher Profiles /
- Researchers /
- Jean Bourbeau, MD, M.Sc., FRCPC
null Jean Bourbeau, MD, M.Sc., FRCPC

Senior Scientist, RI-MUHC
Translational Research in Respiratory Diseases ProgramCentre for Outcomes Research and Evaluation
Professor, Department of Medicine, Faculty of Medicine, McGill University
Department of Medicine, Division of Respiratory Medicine, MUHC
- 514-934-1934 ext. 32185
- jean.bourbeau@mcgill.ca
- External website
Keywords
epidemiology • outcomes research • observational study • COPD • integrated care and self-management
Research Focus
My research focuses on epidemiology and outcomes research using different methodology approaches, including a collaborative self-management program with e-health dedicated to patients and guiding best practices for healthcare professionals. I conduct large and unique observational studies, in particular the Canadian Cohort Obstructive Lung Disease (CanCOLD), a longitudinal observational study which comprises a well characterized phenotype population of chronic obstructive pulmonary disease (COPD) as well as matched non-COPD peers, extending across nine Canadian academic and clinical research institutions.
Research Initiatives
Centre for Innovative Medicine, RI-MUHC
The Canadian Cohort Obstructive Lung Disease (CanCOLD)
Selected Publications
Click on
to see my current publications list
-
Tan WC, Bourbeau J, Nadeau G, Wang W, Barnes N, Landis SH, Kirby M, Hogg JC, Sin DD; CanCOLD Collaborative Research Group. High eosinophil counts predict decline in FEV1: Results from the CanCOLD study. Eur Respir J. 2020 Dec 10:2000838.
-
Yves Lacasse, Frédéric Sériès, François Corbeil, Marc Baltzan, Bruno Paradis, Paula Simão, Araceli Abad Fernández, Cristóbal Esteban, Miguel Guimarães, Jean Bourbeau, Shawn D Aaron, Sarah Bernard, François Maltais, INOX Trial Group. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2020 Sep 17;383(12):1129-1138.
-
*Mostafavi-Pour-Manshadi SM, Naderi N, Mancino P, Li PZ, Tan W, Bourbeau J. Fractional Exhaled Nitric Oxide as an Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease (COPD) with or without Concurrent Diagnosis of Asthma: The Canadian Cohort Obstructive Lung Disease (CanCOLD) COPD. 2020 Aug;17(4):355-365.
-
Bourbeau J, De Sousa Sena R, Taivassalo T, Richard R, Jensen D, Baril J, Rocha Vieira DS, Perrault H. Eccentric versus conventional cycle training to improve muscle strength in advanced COPD: A randomized clinical trial. Respir Physiol Neurobiol. 2020 Feb 9:103414. doi: 10.1016/j.resp.2020.103414.
-
*Farias R, Sedeno M1, Beaucage D, Drouin I, Ouellet I, Joubert A, Abimaroun R, Patel M, Abou Rjeili M, Bourbeau J. Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence. BMJ Open Respir Res. 2019 Apr 9;6(1):e000379. doi: 10.1136/bmjresp-2018-000379. eCollection 2019.